Found 1 clinical trials
RTX-240 Monotherapy
Open label, multicenter, multidose, first-in-human Phase 1/2 study of RTX-240 for the treatment of patients with relapsed/refractory or locally advanced solid tumors.
solid tumor
cancer
solid tumour
platelet count
- 0 views
- 19 Feb, 2024